Cyclacel Pharma (CYCC) Reports Prelim Phase 1/2 Data of Fadraciclib streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
26.10.2022 - Daily dosing of fadraciclib was well tolerated; single agent activity observed across multiple tumor types including 2 PRs in T-cell lymphoma patientsBERKELEY HEIGHTS, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) - Cyclacel Pharmaceuticals, Inc. (NASDAQ: . Seite 1
uniQure Inc.: uniQure to Participate in Multiple Upcoming Industry Conferences in June
~ uniQure to host virtual Research & Development Day on June 22, 2021 ~
LEXINGTON, Mass. and AMSTERDAM, June 02, 2021(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences:
Jefferies Virtual Healthcare Conference, June 1 - 4, 2021
Members of uniQure s management team will participate in virtual one-on-one investor meetings throughout the day on Wednesday, June 2.
A fireside chat with Matt Kapusta (http://uniqure.com/about/management-team-matt-kapusta.php), chief executive officer, will take place the same day from 8:30 to 8:55 a.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investors & Newsroom (http://uniqure.com/investors-newsroom/events-presentations.php) section of the uniQ
~ uniQure to host virtual Research & Development Day on June 22, 2021 ~LEXINGTON, Mass. and AMSTERDAM, June 02, 2021(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for